28336-31-4Relevant articles and documents
-
Goto,G.
, p. 186 - 192 (1977)
-
Synthesis of novel 17-(5′-iodo)triazolyl-3-methoxyestrane epimers via Cu(I)-catalyzed azide-alkyne cycloadditon, and an evaluation of their cytotoxic activity in vitro Dedicated to Professor Irén Vincze on the occasion of her 85th birthday
Schneider, Gyula,G?rbe, Tamás,Mernyák, Erzsébet,W?lfling, János,Holczbauer, Tamás,Czugler, Mátyás,Sohár, Pál,Minorics, Renáta,Zupkó, István
, p. 153 - 165 (2015/05/19)
The regioselective Cu(I)-catalyzed 1,3-dipolar cycloaddition of 3-methoxyestrane 17α- and 17β-azide epimers (3 and 5) with different terminal alkynes afforded novel 1,4-substituted triazolyl derivatives (8a-f and 11a-f). If the Ph3P in the clas
Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
-
, (2008/06/13)
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Androstane steroid, or a pharmaceutical composition containing a semiochemical, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.